Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
CombiMatrix Corp (CBMX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/06/2017 |
8-K
| Quarterly results
Docs:
|
"COMBIMATRIX CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended Nine Months Ended September 30, September 30, 2017 2016 2017 2016 Revenues: Diagnostic services $ 3,977 $ 3,211 $ 11,949 $ 9,190 Royalties 35 37 91 137 Total revenues 4,012 3,248 12,040 9,327 Operating expenses: Cost of services 1,614 1,476 4,754 4,327 Research and development 90 88 260 380 Sales and marketing 967 1,055 3,005 3,532 General and administrative 1,930 1,450 5,449 4,562 Patent amortization and royalties 25 25 75 75 Total operating expenses 4,626 4,094 13,543 12,876 Operating loss Other income : Interest income 7 7 18 19 Interest expense Total other income 4 5 Net loss $ $ $ $ Deemed dividend from issuing Series F convertible preferred stock and warrants $ - $ - $ - $ Deemed dividend paid for r..." |
|
05/04/2017 |
8-K
| Form 8-K - Current report |
02/22/2017 |
8-K
| Form 8-K - Current report |
11/02/2016 |
8-K
| Form 8-K - Current report |
05/04/2016 |
8-K
| Form 8-K - Current report |
02/17/2016 |
8-K
| Quarterly results |
11/04/2015 |
8-K
| Quarterly results |
05/07/2015 |
8-K
| Quarterly results |
02/25/2015 |
8-K
| Quarterly results |
11/04/2014 |
8-K
| Quarterly results |
08/06/2014 |
8-K
| Quarterly results |
05/07/2014 |
8-K
| Quarterly results
Docs:
|
"COMBIMATRIX CORPORATION CONSOLIDATED SUMMARY FINANCIAL INFORMATION Three Months Ended March 31, 2014 2013 Revenues: Diagnostic services $ 1,790 $ 1,586 Royalties 32 25 Total revenues 1,822 1,611 Operating expenses: Cost of services 998 937 Research and development 134 183 Sales and marketing 886 641 General and administrative 1,757 1,373 Patent amortization and royalties 32 60 Total operating expenses 3,807 3,194 Operating loss Other income : Interest income 5 — Interest expense Warrant derivative gain — 1,199 Total other income 897 Net loss $ $ Deemed dividends from issuing Series B convertible preferred stock $ — $ Series A convertible preferred stock dividends — Net loss attributable to common stockholders $ $ Basic and diluted net income per share $ $ Deemed dividends from issuing S..." |
|
02/19/2014 |
8-K
| Quarterly results |
05/08/2013 |
8-K
| Form 8-K - Current report |
02/27/2013 |
8-K
| Form 8-K - Current report |
11/07/2012 |
8-K
| Form 8-K - Current report |
05/11/2012 |
8-K
| Form 8-K - Current report |
02/29/2012 |
8-K
| Form 8-K - Current report |
11/10/2011 |
8-K
| Form 8-K - Current report |
08/10/2011 |
8-K
| Form 8-K - Current report |
05/11/2011 |
8-K
| Form 8-K - Current report |
02/24/2011 |
8-K
| Form 8-K - Current report |
11/10/2010 |
8-K
| Form 8-K - Current report |
05/04/2010 |
8-K
| Form 8-K - Current report |
03/10/2010 |
8-K
| Form 8-K - Current report |
11/12/2009 |
8-K
| Form 8-K - Current report |
08/12/2009 |
8-K
| Form 8-K - Current report |
05/06/2009 |
8-K
| Form 8-K - Current report |
11/06/2008 |
8-K
| Form 8-K - Current report |
08/13/2008 |
8-K
| Form 8-K - Current report |
05/14/2008 |
8-K
| Form 8-K - Current report |
10/24/2007 |
8-K
| Form 8-K - Current report |
|
|